{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "12162464", "DateCompleted": {"Year": "2003", "Month": "02", "Day": "14"}, "DateRevised": {"Year": "2021", "Month": "12", "Day": "03"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0300-8177", "JournalIssue": {"Volume": "234-235", "Issue": "1-2", "PubDate": {"Year": "2002", "Season": "May-Jun"}}, "Title": "Molecular and cellular biochemistry", "ISOAbbreviation": "Mol Cell Biochem"}, "ArticleTitle": "Upregulation of phosphoinositide 3-kinase and protein kinase B in alveolar macrophages following ozone inhalation. Role of NF-kappaB and STAT-1 in ozone-induced nitric oxide production and toxicity.", "Pagination": {"StartPage": "91", "EndPage": "98", "MedlinePgn": "91-8"}, "Abstract": {"AbstractText": ["Inhalation of toxic doses of ozone causes lung injury and inflammation in humans and experimental animals. Using a rodent model of ozone toxicity, we have previously demonstrated that macrophages recruited to the lung following exposure to this oxidant contribute to the pathogenesis of tissue injury. In the present studies we analyzed potential mechanisms regulating alveolar macrophage activity following ozone inhalation and the role of inflammatory mediators in toxicity. Treatment of mice with ozone (0.8 ppm, 3 h) resulted in increased expression of inducible nitric oxide synthase (iNOS) protein and production of nitric oxide (NO) and peroxynitrite by alveolar macrophages. In contrast, these effects were not observed in macrophages from transgenic mice with a targeted disruption of the gene for iNOS, or in mice overexpressing superoxide dismutase. Moreover, ozone toxicity, as measured by bronchoalveolar lavage protein levels and nitrotyrosine staining of the lung was prevented in both of these transgenic mouse strains. The promoter/enhancer region of the iNOS gene contains binding sites for the transcription factors NF-kappaB and STAT-1 which regulate the activity of the gene. Ozone inhalation resulted in a rapid and prolonged activation of NF-kappaB in alveolar macrophages. Phosphoinositide 3-kinase (PI 3-K) and its down stream target, protein kinase B (PKB), which are known to regulate NF-kappaB activity, also increased in alveolar macrophages following ozone inhalation. These data, together with our findings that inhibitors of PI 3-K block NO production, suggest that these proteins are important in controlling expression of iNOS. Furthermore, the fact that macrophages from NF-kappaB p50 knockout mice did not generate reactive nitrogen intermediates and that these mice were protected from ozone induced toxicity demonstrate the importance of the NF-kappaB signaling pathway in lung injury. We also found that STAT-1 nuclear binding activity and STAT-1 protein expression were upregulated in macrophages from ozone treated animals. Taken together, these data suggest that biochemical signaling pathways that control the expression of genes critical for the inflammatory process play a role in ozone toxicity."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Environmental and Occupational Health Sciences Institute, Rutgers University and University of Medicine and Dentistry of New Jersey, Piscataway, USA. laskin@eohsi.rutgers.edu"}], "Identifier": [], "LastName": "Laskin", "ForeName": "Debra L", "Initials": "DL"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Fakhrzadeh", "ForeName": "Ladan", "Initials": "L"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Heck", "ForeName": "Diane E", "Initials": "DE"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Gerecke", "ForeName": "Donald", "Initials": "D"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Laskin", "ForeName": "Jeffrey D", "Initials": "JD"}], "GrantList": [{"GrantID": "ES04738", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "ES05022", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "ES06897", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "GM34310", "Acronym": "GM", "Agency": "NIGMS NIH HHS", "Country": "United States"}, {"GrantID": "HL67708", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, U.S. Gov't, P.H.S."]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Mol Cell Biochem", "NlmUniqueID": "0364456", "ISSNLinking": "0300-8177"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "DNA-Binding Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}, {"RegistryNumber": "0", "NameOfSubstance": "Proto-Oncogene Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "STAT1 Transcription Factor"}, {"RegistryNumber": "0", "NameOfSubstance": "Stat1 protein, mouse"}, {"RegistryNumber": "0", "NameOfSubstance": "Trans-Activators"}, {"RegistryNumber": "31C4KY9ESH", "NameOfSubstance": "Nitric Oxide"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "EC 1.14.13.39", "NameOfSubstance": "Nitric Oxide Synthase"}, {"RegistryNumber": "EC 1.14.13.39", "NameOfSubstance": "Nitric Oxide Synthase Type II"}, {"RegistryNumber": "EC 1.14.13.39", "NameOfSubstance": "Nos2 protein, mouse"}, {"RegistryNumber": "EC 2.7.11.1", "NameOfSubstance": "Protein Serine-Threonine Kinases"}, {"RegistryNumber": "EC 2.7.11.1", "NameOfSubstance": "Proto-Oncogene Proteins c-akt"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Administration, Inhalation"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Bronchoalveolar Lavage Fluid"}, {"QualifierName": ["metabolism"], "DescriptorName": "DNA-Binding Proteins"}, {"QualifierName": ["drug effects"], "DescriptorName": "Enzyme Induction"}, {"QualifierName": ["drug effects", "enzymology", "metabolism"], "DescriptorName": "Macrophages, Alveolar"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred C57BL"}, {"QualifierName": [], "DescriptorName": "Mice, Transgenic"}, {"QualifierName": ["metabolism"], "DescriptorName": "NF-kappa B"}, {"QualifierName": ["metabolism"], "DescriptorName": "Nitric Oxide"}, {"QualifierName": ["biosynthesis", "genetics"], "DescriptorName": "Nitric Oxide Synthase"}, {"QualifierName": [], "DescriptorName": "Nitric Oxide Synthase Type II"}, {"QualifierName": ["administration & dosage", "pharmacology", "toxicity"], "DescriptorName": "Ozone"}, {"QualifierName": ["metabolism"], "DescriptorName": "Phosphatidylinositol 3-Kinases"}, {"QualifierName": [], "DescriptorName": "Protein Serine-Threonine Kinases"}, {"QualifierName": ["metabolism"], "DescriptorName": "Proto-Oncogene Proteins"}, {"QualifierName": [], "DescriptorName": "Proto-Oncogene Proteins c-akt"}, {"QualifierName": [], "DescriptorName": "STAT1 Transcription Factor"}, {"QualifierName": [], "DescriptorName": "Time Factors"}, {"QualifierName": ["metabolism"], "DescriptorName": "Trans-Activators"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "J Biol Chem. 1998 Nov 6;273(45):29411-6", "ArticleIdList": ["9792644"]}, {"Citation": "Immunopharmacol Immunotoxicol. 1996 Nov;18(4):597-608", "ArticleIdList": ["8933172"]}, {"Citation": "J Mol Med (Berl). 1996 Dec;74(12):749-69", "ArticleIdList": ["8974017"]}, {"Citation": "Annu Rev Physiol. 1995;57:737-69", "ArticleIdList": ["7539995"]}, {"Citation": "J Toxicol Environ Health B Crit Rev. 1999 Jan-Mar;2(1):31-86", "ArticleIdList": ["10081525"]}, {"Citation": "Methods. 1996 Aug;10(1):61-70", "ArticleIdList": ["8812646"]}, {"Citation": "Annu Rev Pharmacol Toxicol. 1995;35:655-77", "ArticleIdList": ["7598511"]}, {"Citation": "Clin Invest Med. 1999 Dec;22(6):236-55", "ArticleIdList": ["10664866"]}, {"Citation": "J Leukoc Biol. 1997 Apr;61(4):452-8", "ArticleIdList": ["9103232"]}, {"Citation": "J Clin Invest. 1987 Feb;79(2):319-26", "ArticleIdList": ["3543052"]}, {"Citation": "Science. 1999 Apr 9;284(5412):309-13", "ArticleIdList": ["10195894"]}, {"Citation": "Chest. 1994 Mar;105(3 Suppl):79S-84S", "ArticleIdList": ["8131620"]}, {"Citation": "Pharmacol Res. 1999 Nov;40(5):423-7", "ArticleIdList": ["10527657"]}, {"Citation": "Free Radic Biol Med. 2001 Mar 1;30(5):463-88", "ArticleIdList": ["11182518"]}, {"Citation": "Am J Respir Cell Mol Biol. 1995 Aug;13(2):125-32", "ArticleIdList": ["7542894"]}, {"Citation": "J Appl Toxicol. 1996 Jul-Aug;16(4):309-15", "ArticleIdList": ["8854217"]}, {"Citation": "Methods Enzymol. 1999;301:367-73", "ArticleIdList": ["9919585"]}, {"Citation": "Biochem Soc Trans. 1993 May;21(2):330-4", "ArticleIdList": ["8395426"]}, {"Citation": "J Immunol. 2000 Feb 1;164(3):1355-63", "ArticleIdList": ["10640750"]}, {"Citation": "Am J Respir Cell Mol Biol. 2002 Apr;26(4):413-9", "ArticleIdList": ["11919077"]}, {"Citation": "Cytokine Growth Factor Rev. 1998 Jun;9(2):117-23", "ArticleIdList": ["9754706"]}, {"Citation": "J Leukoc Biol. 1996 Oct;60(4):473-9", "ArticleIdList": ["8864131"]}, {"Citation": "Cell Signal. 2001 Feb;13(2):85-94", "ArticleIdList": ["11257452"]}, {"Citation": "Anal Biochem. 1982 Oct;126(1):131-8", "ArticleIdList": ["7181105"]}, {"Citation": "Am J Respir Cell Mol Biol. 1993 Apr;8(4):384-92", "ArticleIdList": ["8476632"]}, {"Citation": "J Leukoc Biol. 1994 Dec;56(6):759-68", "ArticleIdList": ["7527832"]}, {"Citation": "J Biol Chem. 1997 Nov 14;272(46):29167-73", "ArticleIdList": ["9360994"]}, {"Citation": "FASEB J. 1992 Sep;6(12):3051-64", "ArticleIdList": ["1381691"]}, {"Citation": "Life Sci. 1996;58(14):1139-48", "ArticleIdList": ["8614265"]}, {"Citation": "Trends Endocrinol Metab. 1994 Nov;5(9):377-82", "ArticleIdList": ["18407233"]}, {"Citation": "Rev Environ Health. 1998 Jan-Jun;13(1-2):59-71", "ArticleIdList": ["9718622"]}, {"Citation": "Annu Rev Immunol. 1997;15:563-91", "ArticleIdList": ["9143700"]}, {"Citation": "Trends Biochem Sci. 1997 Jul;22(7):267-72", "ArticleIdList": ["9255069"]}, {"Citation": "Am J Respir Cell Mol Biol. 1994 Sep;11(3):279-86", "ArticleIdList": ["8086166"]}, {"Citation": "J Immunol. 1993 Dec 15;151(12):7196-205", "ArticleIdList": ["7505023"]}, {"Citation": "J Immunol. 1996 Feb 15;156(4):1578-86", "ArticleIdList": ["8568263"]}, {"Citation": "Exp Cell Res. 1999 Nov 25;253(1):7-14", "ArticleIdList": ["10579906"]}, {"Citation": "J Leukoc Biol. 1994 Feb;55(2):141-6", "ArticleIdList": ["8301209"]}, {"Citation": "Nature. 1999 Sep 2;401(6748):82-5", "ArticleIdList": ["10485710"]}, {"Citation": "Am J Respir Cell Mol Biol. 1996 Jun;14(6):516-25", "ArticleIdList": ["8652180"]}, {"Citation": "Annu Rev Immunol. 1984;2:283-318", "ArticleIdList": ["6100475"]}, {"Citation": "Am J Respir Cell Mol Biol. 1994 Oct;11(4):426-31", "ArticleIdList": ["7522485"]}, {"Citation": "Science. 1995 Mar 10;267(5203):1485-8", "ArticleIdList": ["7878466"]}, {"Citation": "Mol Cell Biol. 1999 Jul;19(7):4798-805", "ArticleIdList": ["10373529"]}, {"Citation": "Ann Ist Super Sanita. 1990;26(3-4):255-61", "ArticleIdList": ["2128676"]}]}], "History": [{"Year": "2002", "Month": "8", "Day": "7", "Hour": "10", "Minute": "0"}, {"Year": "2003", "Month": "2", "Day": "15", "Hour": "4", "Minute": "0"}, {"Year": "2002", "Month": "8", "Day": "7", "Hour": "10", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["12162464"]}}], "PubmedBookArticle": []}